发明名称 |
LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS. |
摘要 |
The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I) : as described herein. The subject invention also provides packages and pharmaceutical compositions comprising laquinimod and a compound of formula (I) as described herein. The subject invention further provides uses of said compounds, pharmaceutical compositions and packages in treating a subject afflicted with a form of MS or presenting a CIS. |
申请公布号 |
MX2016003763(A) |
申请公布日期 |
2016.10.28 |
申请号 |
MX20160003763 |
申请日期 |
2014.09.26 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
Joel KAYE;Volker KNAPPERTZ |
分类号 |
A61K31/225 |
主分类号 |
A61K31/225 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|